Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-03

Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and immunogenicity of one or two booster doses of an H5N6 influenza vaccine in adults previously primed with H5N1 or un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • H5N6 influenza vaccine

Snippet

Sponsor: Seqirus | Conditions: Influenza, Human, Influenza in Birds | Phase 2 | Status: COMPLETED